当前位置: 首页 >> 检索结果
共有 614 条符合本次的查询结果, 用时 1.5151131 秒

481. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.

作者: C O Bingham.;A I Sebba.;B R Rubin.;G E Ruoff.;J Kremer.;S Bird.;S S Smugar.;B J Fitzgerald.;K O'Brien.;A M Tershakovec.
来源: Rheumatology (Oxford). 2007年46卷3期496-507页
To compare the efficacy of etoricoxib 30 mg with the generally maximum recommended dose of celecoxib, 200 mg, in the treatment of osteoarthritis (OA) in two identically designed studies.

482. Is acupuncture more effective than sham acupuncture in relieving pain in patients with low back pain?

作者: Daniel J Clauw.;Richard E Harris.
来源: Nat Clin Pract Rheumatol. 2006年2卷7期362-3页

483. Does flexion-distraction help treat chronic low back pain?

作者: Martijn W Heymans.;Johannes R Anema.;Henrica C W de Vet.;Willem van Mechelen.
来源: Nat Clin Pract Rheumatol. 2006年2卷7期360-1页

484. Is the long-term use of systemic corticosteroids beneficial in the management of Behçet's syndrome?

作者: Shunsei Hirohata.
来源: Nat Clin Pract Rheumatol. 2006年2卷7期358-9页

485. Glucosamine and chondroitin sulfate in knee osteoarthritis: where now?

作者: David T Felson.
来源: Nat Clin Pract Rheumatol. 2006年2卷7期356-7页

486. Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide.

作者: Jennifer R Elliott.;Susan Manzi.
来源: Nat Clin Pract Rheumatol. 2006年2卷7期354-5页

487. Efficacy and safety of infliximab for the treatment of psoriatic arthritis.

作者: Christopher Ritchlin.
来源: Nat Clin Pract Rheumatol. 2006年2卷6期300-1页

488. Treating axial manifestations in ankylosing spondylitis in the presence of peripheral arthritis.

作者: Wonuk Lee.;Michael H Weisman.
来源: Nat Clin Pract Rheumatol. 2006年2卷6期298-9页

489. Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy.

作者: Graciela S Alarcón.
来源: Nat Clin Pract Rheumatol. 2006年2卷6期296-7页

490. Utility of cognitive behavioral therapy as a treatment for insomnia in patients with fibromyalgia.

作者: David A Williams.
来源: Nat Clin Pract Rheumatol. 2006年2卷4期190-1页

491. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?

作者: Stephen M Krane.
来源: Nat Clin Pract Rheumatol. 2006年2卷4期186-7页

492. Glucocorticoid therapy in rheumatoid arthritis: intra-articular injections versus systemic administration.

作者: Edward D Harris.
来源: Nat Clin Pract Rheumatol. 2006年2卷4期184-5页

493. Early rheumatoid arthritis: combination therapy with disease-modifying antirheumatic drugs and low-dose glucocorticoids?

作者: John Kirwan.
来源: Nat Clin Pract Rheumatol. 2006年2卷4期182-3页

494. Does acupuncture help reduce pain in patients with fibromyalgia?

作者: Daniel J Clauw.
来源: Nat Clin Pract Rheumatol. 2005年1卷2期76-7页

495. Does hormone replacement therapy affect disease activity in patients with systemic lupus erythematosus?

作者: Rosalind Ramsey-Goldman.
来源: Nat Clin Pract Rheumatol. 2005年1卷2期72-3页

496. A clinical trial of specialist footwear for patients with rheumatoid arthritis.

作者: A E Williams.;K Rome.;C J Nester.
来源: Rheumatology (Oxford). 2007年46卷2期302-7页
The structural and functional changes in the RA foot often affect the patient's gait and mobility, impacting on the patient's quality of life. Successful management of these foot pathologies and resultant problems can involve the provision of specialist therapeutic footwear. The aim of the study was to evaluate the value of a new footwear design based on patients' opinions compared with a traditional footwear design.

497. A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients.

作者: J C Buckland-Wright.;E A Messent.;C O Bingham.;R J Ward.;C Tonkin.
来源: Rheumatology (Oxford). 2007年46卷2期257-64页
To determine whether risedronate (RIS) slows down trabecular bone loss in the medial compartment of the proximal tibia, a characteristic of patients with progressive knee osteoarthritis (OA).

498. Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials.

作者: M J Yelland.;C J Nikles.;N McNairn.;C B Del Mar.;P J Schluter.;R M Brown.
来源: Rheumatology (Oxford). 2007年46卷1期135-40页
To assess the use of n-of-1 trials for short-term choice of drugs for osteoarthritis, with particular reference to comparing the efficacy of sustained-release [SR] paracetamol with celecoxib in individual patients.

499. Validation of a Dutch translation of the fibromyalgia impact questionnaire.

作者: T R Zijlstra.;E Taal.;M A F J van de Laar.;J J Rasker.
来源: Rheumatology (Oxford). 2007年46卷1期131-4页
To validate a Dutch translation of the fibromyalgia impact questionnaire (FIQ).

500. Undergraduate musculoskeletal examination teaching by trained patient educators--a comparison with doctor-led teaching.

作者: N Raj.;L J Badcock.;G A Brown.;C M Deighton.;S C O'Reilly.
来源: Rheumatology (Oxford). 2006年45卷11期1404-8页
To compare the core hand and knee examination skills gained by undergraduates taught either by trained patient educators (PEs) or by doctors.
共有 614 条符合本次的查询结果, 用时 1.5151131 秒